Search
for
Sort by
Research 601–630 of 1000+
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Rare Association of Congenital Triangular Alopecia with Vitiligo
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Treatment of Alopecia Universalis in a Child with Down Syndrome
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Perceived Stigma Among Adults With Alopecia Areata in the United States
- Simultaneous Estimation of Minoxidil and Tofacitinib Citrate in Bulk and Topical Gel - A Validated UV-spectrophotometric Technique
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case–Control Study
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The Roles of Exosomes in Regulating Hair Follicle Growth
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization